Katherine Hein, MD
Plastic and Reconstructive Surgery · Natick, MANPI 1598780363
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Galderma Laboratories, L.p. at 27.0% of the total. Reporting peaked in 2021 at $401 and has fallen 94.3% since, to $23 in 2025. That places this record below the midpoint for plastic and reconstructive surgery clinicians in MA, where the typical reported total is $1,054.
Across 41 payments — averaging $25.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$284
- AbbVie$226
- Sientra, Inc.$174
- Mentor Worldwide LLC$148
- Smith+Nephew$64
- Amgen$36
- plus $121 from 5 others
What the payments were for
- Food & beverage$1,054100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 5 | $284 |
| AbbVie(2 entities) | 10 | $226 |
| Sientra, Inc. | 8 | $174 |
| Mentor Worldwide LLC | 6 | $148 |
| Smith+Nephew | 4 | $64 |
| Amgen | 2 | $36 |
| AstraZeneca | 2 | $32 |
| Apyx Medical Corporation | 1 | $27 |
| Bayer | 1 | $25 |
| Eisai Inc. | 1 | $21 |
| Blueprint Medicines Corporation | 1 | $16 |
How this compares
$1,054 in reported general payments places this provider in the 50th percentile of 67 plastic and reconstructive surgery providers in Massachusetts.
See all plastic and reconstructive surgery providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 13 | $15 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Natick
- Kyle EberlinBoston$445K
- Guy RochmanMilton$125K
- Dennis OrgillBoston$87K
- Glen BrooksLongmeadow$78K
- Jonathan FriedstatBoston$59K
- Ashley BoustanyBoston$46K
- Devin O'Brien-CoonBoston$34K
- Raymond DunnWorcester$31K
- Jonathan BekiszBoston$23K
- Krystle TuanoBoston$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.